{"altmetric_id":12573263,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":62},"twitter":{"unique_users_count":46,"unique_users":["KarenSweiss","Myeloma_Doc","DrOlaLandgren","jose6xxx","BuckeyeMyeloma","Transplant_Doc","TBSsteharding","ClinChemINFO","IMFsupport","brendanweiss","FrancescoTurtu1","elyarams","IMFprattMYELOMA","BindingSiteHaem","Nicoco_G","Taxkourel","ymori117","jinichimori","gedefo_sefh","Shimo_hematol","BloodJournal","bloodworkapp","bahmohamm","queizan","hematologiaHGSE","bmtojc","PLMcCarthyMD","DQBMD","RenoHemonc","marrowdoc","nishihori","erperpersona","BirgerArmstrong","mtmdphd","VincentRK","drkomanduri","roverome","ShikhaJainMD","MyelomaTeacher","drcbsteer","e_campagnaro","neuherman","safaridoc","MayoMyeloma","AndrewCowanMD","doctoreebs"],"posts_count":60},"facebook":{"unique_users_count":1,"unique_users":["1569588320003106"],"posts_count":1},"googleplus":{"unique_users_count":1,"unique_users":["The Binding Site"],"posts_count":1}},"selected_quotes":["We use FLCs a lot instead of urine M spike. But periodic assessment of urine is still needed. Clinical trial criteria also r\u2026","CME article: superiority of serum free light chain response evaluation in #myeloma #mmsm","\u2018Serum Free Light Chains Should be the Target of Response Evaluation in Light Chain #Myeloma Rather than Urine\u2019-","In #myeloma (but not #Amyloidosis), no need to bring in 24hr urine to your doctor's office. Good riddance.","Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma"],"citation":{"abstract":"Guidelines for monitoring multiple myeloma patients expressing light chains only (light chain multiple myeloma; LCMM) rely on measurements of the monoclonal protein in urine. Alternatively serum free light chain (sFLC) measurements have better sensitivity over urine methods, however, demonstration that improved sensitivity provides any clinical benefit is lacking. Here we compared the performance of serum and urine measurements in 113 (72\u03ba, 41\u03bb) newly diagnosed LCMM patients enrolled onto the IFM-2009 trial. All diagnostic samples (100%) had an abnormal \u03ba\/\u03bb sFLC ratio, and involved (monoclonal) FLC (iFLC) expressed at levels deemed measurable for monitoring (\u2265100mg\/L). By contrast, only 64% patients had measurable levels of the monoclonal protein (\u2265200mg\/24h) in urine protein electrophoresis (UPEP). After 1 and 3 treatment cycles, iFLC remained elevated in 71% and 46% patients, respectively, whilst UPEP reported a positive result in 37% and 18%; all the patients with a positive UPEP at cycle 3 also had elevated iFLC levels. Importantly, elevated iFLC or an abnormal \u03ba\/\u03bb sFLC ratio after 3 treatment cycles associated with poorer PFS (p=0.006 and p<0.0001, respectively), whereas positive UPEP or urine immunofixation (uIFE) did not. In addition, patients with an abnormal \u03ba\/\u03bb sFLC ratio had poorer overall survival (p=0.022). Finally, early normalisation of \u03ba\/\u03bb sFLC ratio but not negative uIFE predicted achieving negative minimal residual disease, as determined by flow cytometry, after consolidation therapy (100% positive predictive value). We conclude that improved sensitivity and prognostic value of serum over urine measurements provide a strong basis for recommending the former for monitoring LCMM patients.","altmetric_jid":"4f6fa60e3cf058f610006cba","authors":["Thomas Dejoie","Jill Corre","Helene Caillon","Cyrille Hulin","Aurore Perrot","Denis Caillot","Eileen Boyle","Marie-Lorraine Chretien","Jean Fontan","Karim Belhadj","Sabine Brechignac","Olivier Decaux","Laurent Voillat","Philippe Rodon","Olivier Fitoussi","Carla Araujo","Lotfi Benboubker","Charlotte Fontan","Mourad Tiab","Pascal Godmer","Odile Luycx","Olivier Allangba","Jean-Michel Pignon","Jean-Gabriel Fuzibet","Laurence Legros","Anne-Marie Stoppa","Mamoun Dib","Brigitte Pegourie","Frederique Orsini-Piocelle","Lionel Karlin","Bertrand Arnulf","Murielle Roussel","Laurent Garderet","Mohamad Mohty","Nathalie Meuleman","Chantal Doyen","Pascal Lenain","Margaret Macro","Xavier Leleu","Thierry Facon","Philippe Moreau","Michel Attal","Herve Avet-Loiseau","Dejoie, Thomas","Corre, Jill","Caillon, Helene","Hulin, Cyrille","Perrot, Aurore","Caillot, Denis","Boyle, Eileen","Chretien, Marie-Lorraine","Fontan, Jean","Belhadj, Karim","Brechignac, Sabine","Decaux, Olivier","Voillat, Laurent","Rodon, Philippe","Fitoussi, Olivier","Araujo, Carla","Benboubker, Lotfi","Fontan, Charlotte","Tiab, Mourad","Godmer, Pascal","Luycx, Odile","Allangba, Olivier","Pignon, Jean-Michel","Fuzibet, Jean-Gabriel","Legros, Laurence","Stoppa, Anne-Marie","Dib, Mamoun","Pegourie, Brigitte","Orsini-Piocelle, Frederique","Karlin, Lionel","Arnulf, Bertrand","Roussel, Murielle","Garderet, Laurent","Mohty, Mohamad","Meuleman, Nathalie","Doyen, Chantal","Lenain, Pascal","Macro, Margaret","Leleu, Xavier","Facon, Thierry","Moreau, Philippe","Attal, Michel","Avet-Loiseau, Herve","Anne Marie Stoppa"],"doi":"10.1182\/blood-2016-07-726778","first_seen_on":"2016-10-12T01:31:29+00:00","funders":["niehs","nci"],"issns":["1528-0020","0006-4971"],"journal":"Blood","last_mentioned_on":1491964808,"links":["http:\/\/www.bloodjournal.org\/content\/early\/2016\/10\/11\/blood-2016-07-726778?sso-checked=true","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27729323","http:\/\/www.bloodjournal.org\/content\/early\/2016\/10\/11\/blood-2016-07-726778?papetoc=&sso-checked=true","http:\/\/www.bloodjournal.org\/content\/128\/25\/2941?etoc=&sso-checked=true","http:\/\/www.bloodjournal.org\/content\/128\/25\/2941?sso-checked=true","http:\/\/www.bloodjournal.org\/content\/128\/25\/2941?rss=1&sso-checked=true","http:\/\/www.bloodjournal.org\/content\/early\/2016\/10\/11\/blood-2016-07-726778?sso-checked=true&utm_content=44452475&utm_medium=social&utm_source=twitter","http:\/\/www.bloodjournal.org\/content\/early\/2016\/10\/11\/blood-2016-07-726778?sso-checked=true&utm_content=50850376&utm_medium=social&utm_source=twitter"],"pdf_url":"http:\/\/www.bloodjournal.org\/content\/bloodjournal\/early\/2016\/10\/11\/blood-2016-07-726778.full.pdf","pmid":"27729323","pubdate":"2016-01-01T00:00:00+00:00","publisher":"American Society of Hematology","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"},{"name":"Paediatrics And Reproductive Medicine","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Immunology and Microbiology","Biochemistry, Genetics and Molecular Biology"],"subjects":["hematology"],"title":"Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines","type":"article","uri":"http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood-2016-07-726778","mendeley_url":"http:\/\/www.mendeley.com\/research\/serum-free-light-chains-not-urine-specimens-used-evaluate-response-lightchain-multiple-myeloma"},"altmetric_score":{"score":28,"score_history":{"1y":28,"6m":1.6,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":28},"context_for_score":{"all":{"total_number_of_other_articles":8323950,"mean":7.0157979237904,"rank":318323,"this_scored_higher_than_pct":96,"this_scored_higher_than":8004112,"rank_type":"exact","sample_size":8323950,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":250765,"mean":12.683301382973,"rank":18152,"this_scored_higher_than_pct":92,"this_scored_higher_than":232532,"rank_type":"exact","sample_size":250765,"percentile":92},"this_journal":{"total_number_of_other_articles":9778,"mean":5.680585660223,"rank":276,"this_scored_higher_than_pct":97,"this_scored_higher_than":9500,"rank_type":"exact","sample_size":9778,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":180,"mean":5.2311396648045,"rank":3,"this_scored_higher_than_pct":98,"this_scored_higher_than":177,"rank_type":"exact","sample_size":180,"percentile":98}}},"demographics":{"poster_types":{"member_of_the_public":27,"researcher":10,"practitioner":7,"science_communicator":2},"users":{"twitter":{"cohorts":{"Scientists":10,"Members of the public":27,"Science communicators (journalists, bloggers, editors)":2,"Practitioners (doctors, other healthcare professionals)":7}},"mendeley":{"by_status":{"Researcher":4,"Student  > Master":1,"Other":2},"by_discipline":{"Medicine and Dentistry":5,"Immunology and Microbiology":1,"Unspecified":1}}},"geo":{"twitter":{"US":19,"ES":4,"GB":2,"FR":1,"JP":1,"CA":1,"AU":1,"DK":1},"mendeley":{"SE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/KarenSweiss\/statuses\/786016345787764736","license":"gnip","citation_ids":[12573263],"posted_on":"2016-10-12T01:31:14+00:00","author":{"name":"Karen Sweiss","image":"https:\/\/pbs.twimg.com\/profile_images\/899816186808086528\/6vHwAO73_normal.jpg","description":"Clinical Pharmacist, Clinical Assistant Professor, Hematology and BMT, University of Illinois at Chicago","id_on_source":"KarenSweiss","tweeter_id":"397479698","geo":{"lt":null,"ln":null},"followers":571},"tweet_id":"786016345787764736"},{"url":"http:\/\/twitter.com\/Myeloma_Doc\/statuses\/786554582872760321","license":"gnip","citation_ids":[12573263],"posted_on":"2016-10-13T13:10:00+00:00","author":{"name":"Robert Z. Orlowski","url":"http:\/\/faculty.mdanderson.org\/robert_orlowski\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1118389100\/-1_normal.jpg","description":"Director of Myeloma Section at MD Anderson Cancer Center; Translational researcher who hates myeloma. Tweets are my own. Retweets \u2260 endorsements.","id_on_source":"Myeloma_Doc","tweeter_id":"187354183","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":7328},"tweet_id":"786554582872760321"},{"url":"http:\/\/twitter.com\/DrOlaLandgren\/statuses\/786563034785382400","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2016-10-13T13:43:35+00:00","author":{"name":"Ola Landgren, M.D.","image":"https:\/\/pbs.twimg.com\/profile_images\/624397059093856256\/6B48fZZD_normal.jpg","description":"Professor of Medicine & Chief of Multiple Service at Memorial Sloan-Kettering in New York City. I tweet on medicine & health. Tweets & opinions are mine.","id_on_source":"DrOlaLandgren","tweeter_id":"2257190339","geo":{"lt":null,"ln":null},"followers":2749},"tweet_id":"786563034785382400"},{"url":"http:\/\/twitter.com\/jose6xxx\/statuses\/786563740791607297","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2016-10-13T13:46:24+00:00","author":{"name":"Jos\u00e9 L. Garc\u00eda","url":"https:\/\/es.linkedin.com\/in\/jose0","image":"https:\/\/pbs.twimg.com\/profile_images\/610876993354264577\/iveN_9iL_normal.jpg","description":"Especialista en Bioqu\u00edmica Cl\u00ednica y An\u00e1lisis Cl\u00ednicos. Complejo Hospitalario Universitario de Granada","id_on_source":"jose6xxx","tweeter_id":"406496525","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":495},"tweet_id":"786563740791607297"},{"url":"http:\/\/twitter.com\/BuckeyeMyeloma\/statuses\/786571751664787456","license":"gnip","citation_ids":[12573263],"posted_on":"2016-10-13T14:18:14+00:00","author":{"name":"Craig Hofmeister","url":"http:\/\/ohiomyeloma.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000842174932\/59724ae276911fe037b0e94520386f64_normal.jpeg","description":"Hematologist at Ohio State. All things myeloma, primetime and beyond. Tweets are my own.","id_on_source":"BuckeyeMyeloma","tweeter_id":"2234845399","geo":{"lt":39.96118,"ln":-82.99879,"country":"US"},"followers":996},"tweet_id":"786571751664787456"},{"url":"http:\/\/twitter.com\/BuckeyeMyeloma\/statuses\/786571913573310464","license":"gnip","citation_ids":[12573263],"posted_on":"2016-10-13T14:18:52+00:00","author":{"name":"Craig Hofmeister","url":"http:\/\/ohiomyeloma.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000842174932\/59724ae276911fe037b0e94520386f64_normal.jpeg","description":"Hematologist at Ohio State. All things myeloma, primetime and beyond. Tweets are my own.","id_on_source":"BuckeyeMyeloma","tweeter_id":"2234845399","geo":{"lt":39.96118,"ln":-82.99879,"country":"US"},"followers":996},"tweet_id":"786571913573310464"},{"url":"http:\/\/twitter.com\/Transplant_Doc\/statuses\/786577116779253760","license":"gnip","citation_ids":[12573263],"posted_on":"2016-10-13T14:39:33+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3370},"tweet_id":"786577116779253760"},{"url":"http:\/\/twitter.com\/Transplant_Doc\/statuses\/786577157405364224","license":"gnip","rt":["BuckeyeMyeloma"],"citation_ids":[12573263],"posted_on":"2016-10-13T14:39:42+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3370},"tweet_id":"786577157405364224"},{"url":"http:\/\/twitter.com\/TBSsteharding\/statuses\/786629463450783744","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2016-10-13T18:07:33+00:00","author":{"name":"Stephen Harding","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000769547668\/2847d950f397d56d8db9ed5df461d2eb_normal.jpeg","id_on_source":"TBSsteharding","tweeter_id":"1975260703","geo":{"lt":null,"ln":null},"followers":131},"tweet_id":"786629463450783744"},{"url":"http:\/\/twitter.com\/ClinChemINFO\/statuses\/786709472421023745","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2016-10-13T23:25:29+00:00","author":{"name":"ClinChemINFO","url":"http:\/\/www.clinicalchemistry.info","image":"https:\/\/pbs.twimg.com\/profile_images\/556141595234275329\/392ECMgd_normal.png","id_on_source":"ClinChemINFO","tweeter_id":"2981358863","geo":{"lt":null,"ln":null},"followers":534},"tweet_id":"786709472421023745"},{"url":"http:\/\/twitter.com\/IMFsupport\/statuses\/786730246338936832","license":"gnip","rt":["BuckeyeMyeloma"],"citation_ids":[12573263],"posted_on":"2016-10-14T00:48:02+00:00","author":{"name":"Robin Tuohy","url":"http:\/\/myeloma.org","image":"https:\/\/pbs.twimg.com\/profile_images\/854063793558528000\/PByjypqr_normal.jpg","description":"Senior Director Support Groups, International Myeloma Foundation.   Husband, Michael, dx w\/ myeloma 2000. Living well thx to treatment, research & IMF.","id_on_source":"IMFsupport","tweeter_id":"987194570","geo":{"lt":41.50232,"ln":-72.97872,"country":"US"},"followers":1071},"tweet_id":"786730246338936832"},{"url":"http:\/\/twitter.com\/brendanweiss\/statuses\/786748026400440320","license":"gnip","rt":["BuckeyeMyeloma"],"citation_ids":[12573263],"posted_on":"2016-10-14T01:58:41+00:00","author":{"name":"Brendan Weiss, MD","url":"http:\/\/www.med.upenn.edu\/apps\/faculty\/index.php\/g348\/p8478251","image":"https:\/\/pbs.twimg.com\/profile_images\/3694290317\/c02ab5a1193600119a888908e6b6f4bd_normal.jpeg","description":"Hematologist @PennCancer. Passionate about treating and researching plasma cell disorders: MGUS, SMM, myeloma, amyloidosis, #mmsm. Tweets are my own.","id_on_source":"brendanweiss","tweeter_id":"363212080","geo":{"lt":39.95234,"ln":-75.16379,"country":"US"},"followers":1933},"tweet_id":"786748026400440320"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/statuses\/786908698220240897","license":"gnip","citation_ids":[12573263],"posted_on":"2016-10-14T12:37:08+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"786908698220240897"},{"url":"http:\/\/twitter.com\/elyarams\/statuses\/786916257211842560","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2016-10-14T13:07:10+00:00","author":{"name":"Elyara Soares","image":"https:\/\/pbs.twimg.com\/profile_images\/849310685599346690\/IBuFKSLi_normal.jpg","id_on_source":"elyarams","tweeter_id":"56198013","geo":{"lt":42.27756,"ln":-83.74088,"country":"US"},"followers":181},"tweet_id":"786916257211842560"},{"url":"http:\/\/twitter.com\/IMFprattMYELOMA\/statuses\/786979709481459712","license":"gnip","rt":["BuckeyeMyeloma"],"citation_ids":[12573263],"posted_on":"2016-10-14T17:19:18+00:00","author":{"name":"Carlene Pratt","url":"http:\/\/upland.myeloma.org","image":"https:\/\/pbs.twimg.com\/profile_images\/663911681194463232\/VY4yeONy_normal.jpg","id_on_source":"IMFprattMYELOMA","tweeter_id":"4075766173","geo":{"lt":null,"ln":null},"followers":135},"tweet_id":"786979709481459712"},{"url":"http:\/\/twitter.com\/BindingSiteHaem\/statuses\/786545350832107520","license":"public","citation_ids":[12573263],"posted_on":"2016-10-13T12:33:19+00:00","author":{"name":"Binding Site","url":"http:\/\/www.bindingsite.com","image":"https:\/\/pbs.twimg.com\/profile_images\/466145479625949187\/lZH6z1lj_normal.png","description":"Clinical utility of free light chains (Freelite) & heavy\/light chains (Hevylite) in monoclonal gammopathy #myeloma #nephrology Disclaimer http:\/\/hub.am\/1jLoIuK","id_on_source":"BindingSiteHaem","tweeter_id":"875434993","geo":{"lt":52.48142,"ln":-1.89983,"country":"GB"},"followers":819},"tweet_id":"786545350832107520"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/statuses\/812012732409061376","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-22T19:11:36+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"812012732409061376"},{"url":"http:\/\/twitter.com\/Nicoco_G\/statuses\/812016726653206530","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-22T19:27:28+00:00","author":{"name":"Os \u00e0 Moelle","url":"http:\/\/www.ithem.fr\/david-smadja.html","image":"https:\/\/pbs.twimg.com\/profile_images\/830387447242571776\/D4x8r7Mr_normal.jpg","description":"H\u00e9matologiste #H\u00e9mostase #Thrombose #CardioVascularResearch. PhD Student... #Art #Sant\u00e9","id_on_source":"Nicoco_G","tweeter_id":"392661674","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":749},"tweet_id":"812016726653206530"},{"url":"http:\/\/twitter.com\/Taxkourel\/statuses\/812020830527954945","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-22T19:43:47+00:00","author":{"name":"Taxiarchis Kourelis","image":"https:\/\/pbs.twimg.com\/profile_images\/645004235591979008\/NCzeLuVE_normal.jpg","description":"The MADest DOG at Mayo Clinic (MAD=Myeloma,Amyloid, Dysproteinemia, DOG=Disease Oriented Group).Hate all things Congophilic.Tweets are my own.","id_on_source":"Taxkourel","tweeter_id":"3406182010","geo":{"lt":null,"ln":null},"followers":225},"tweet_id":"812020830527954945"},{"url":"http:\/\/twitter.com\/ymori117\/statuses\/812169253411426304","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-23T05:33:34+00:00","author":{"name":"\u68ee\u3000\u52c7\u4e00","url":"http:\/\/twilog.org\/ymori117","image":"https:\/\/pbs.twimg.com\/profile_images\/848199682329255936\/8L7dBR04_normal.jpg","description":"\u9577\u91ce\u770c\u3067\u8840\u6db2\u5185\u79d1\u533b\u3092\u3057\u3066\u3044\u307e\u3059","id_on_source":"ymori117","tweeter_id":"128218698","geo":{"lt":36.65139,"ln":138.18111,"country":"JP"},"followers":2990},"tweet_id":"812169253411426304"},{"url":"http:\/\/twitter.com\/jinichimori\/statuses\/812192060308484097","license":"gnip","rt":["ymori117"],"citation_ids":[12573263],"posted_on":"2016-12-23T07:04:11+00:00","author":{"name":"\u68ee\u3000\u751a\u4e00","image":"https:\/\/pbs.twimg.com\/profile_images\/499229480791977985\/myvcDGNf_normal.jpeg","description":"\u8840\u6db2\u5185\u79d1\u533b\u30022016\u5e744\u6708\u6771\u4eac\u304b\u3089\u798f\u5cf6\u770c\u3044\u308f\u304d\u5e02\u306b\u8ee2\u5c45\u3002","id_on_source":"jinichimori","tweeter_id":"2345427788","geo":{"lt":null,"ln":null},"followers":133},"tweet_id":"812192060308484097"},{"url":"http:\/\/twitter.com\/gedefo_sefh\/statuses\/812212151674880001","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-23T08:24:01+00:00","author":{"name":"GEDEFO","url":"http:\/\/www.sefh.es","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000753799388\/8561701cfcfbc3a7efa7ec153101b2ab_normal.jpeg","description":"Grupo de Farmacia Oncol\u00f3gica de la SEFH","id_on_source":"gedefo_sefh","tweeter_id":"2184775389","geo":{"lt":39.5,"ln":-3,"country":"ES"},"followers":1989},"tweet_id":"812212151674880001"},{"url":"http:\/\/twitter.com\/Shimo_hematol\/statuses\/812267427689951232","license":"gnip","rt":["ymori117"],"citation_ids":[12573263],"posted_on":"2016-12-23T12:03:40+00:00","author":{"name":"Shimo","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"Shimo_hematol","tweeter_id":"949609022","geo":{"lt":null,"ln":null},"followers":7},"tweet_id":"812267427689951232"},{"url":"http:\/\/twitter.com\/BloodJournal\/statuses\/812319590072061952","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-23T15:30:57+00:00","author":{"name":"Blood Journal","url":"http:\/\/www.bloodjournal.org","image":"https:\/\/pbs.twimg.com\/profile_images\/669620689461248000\/x443s9OU_normal.jpg","description":"Blood, the official journal of @ASH_Hematology, is the most cited peer-reviewed publication in the field of hematology, available weekly in print and online.","id_on_source":"BloodJournal","tweeter_id":"3407436940","geo":{"lt":null,"ln":null},"followers":7787},"tweet_id":"812319590072061952"},{"url":"http:\/\/twitter.com\/bloodworkapp\/statuses\/812346804184449024","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-23T17:19:05+00:00","author":{"name":"BloodWork","url":"http:\/\/bit.ly\/bloodworkappstore","image":"https:\/\/pbs.twimg.com\/profile_images\/741624387586170881\/XZyFlPRv_normal.jpg","description":"All of haematology, 1 tweet at a time: MCQ\/EMQs for specialist trainees. Key updates in clotting, malignant, transfusion, red cell & paeds. #FOAMed","id_on_source":"bloodworkapp","tweeter_id":"741545908232425476","geo":{"lt":null,"ln":null},"followers":1095},"tweet_id":"812346804184449024"},{"url":"http:\/\/twitter.com\/bahmohamm\/statuses\/812347787564216321","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T17:22:59+00:00","author":{"name":"Mohammad Bahmanyar","image":"https:\/\/pbs.twimg.com\/profile_images\/869623054082736129\/CBd8mMbM_normal.jpg","description":"#Hemepath Hematological Pathology Chief Resident, University Of Toronto (Tweets\/Retweets for interest and education not medical advice)","id_on_source":"bahmohamm","tweeter_id":"738528534566572032","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":308},"tweet_id":"812347787564216321"},{"url":"http:\/\/twitter.com\/TBSsteharding\/statuses\/812353329518899200","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T17:45:01+00:00","author":{"name":"Stephen Harding","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000769547668\/2847d950f397d56d8db9ed5df461d2eb_normal.jpeg","id_on_source":"TBSsteharding","tweeter_id":"1975260703","geo":{"lt":null,"ln":null},"followers":131},"tweet_id":"812353329518899200"},{"url":"http:\/\/twitter.com\/queizan\/statuses\/812357245623209984","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T18:00:34+00:00","author":{"name":"Dr. Jos\u00e9 A. Queiz\u00e1n","image":"https:\/\/pbs.twimg.com\/profile_images\/805313113016799232\/jBSTAjA7_normal.jpg","description":"Medico Especialista en Hematologia y Hemoterapia","id_on_source":"queizan","tweeter_id":"2334315479","geo":{"lt":null,"ln":null},"followers":400},"tweet_id":"812357245623209984"},{"url":"http:\/\/twitter.com\/queizan\/statuses\/812357268780052482","license":"gnip","rt":["bloodworkapp"],"citation_ids":[12573263],"posted_on":"2016-12-23T18:00:40+00:00","author":{"name":"Dr. Jos\u00e9 A. Queiz\u00e1n","image":"https:\/\/pbs.twimg.com\/profile_images\/805313113016799232\/jBSTAjA7_normal.jpg","description":"Medico Especialista en Hematologia y Hemoterapia","id_on_source":"queizan","tweeter_id":"2334315479","geo":{"lt":null,"ln":null},"followers":400},"tweet_id":"812357268780052482"},{"url":"http:\/\/twitter.com\/hematologiaHGSE\/statuses\/812363125571862528","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T18:23:56+00:00","author":{"name":"HematologiaHGSegovia","image":"https:\/\/pbs.twimg.com\/profile_images\/561600162808991744\/9jApSNy__normal.jpeg","description":"Twitter no oficial del Servicio de Hematologia y Hemoterapia del Hospital General de Segovia (Espa\u00f1a). Opiniones personales e informaci\u00f3n sobre Hematolog\u00eda.","id_on_source":"hematologiaHGSE","tweeter_id":"3007899819","geo":{"lt":40.94808,"ln":-4.11839,"country":"ES"},"followers":170},"tweet_id":"812363125571862528"},{"url":"http:\/\/twitter.com\/bmtojc\/statuses\/812378226639179776","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T19:23:57+00:00","author":{"name":"BMT Journal Club","url":"http:\/\/www.bmtojc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/534073284682194944\/KlT5ElF5_normal.jpeg","description":"@ASBMT Online Journal Club - Stem cell transplantation. Leukemia. Lymphoma. MDS. Myeloma. #bmtsm","id_on_source":"bmtojc","tweeter_id":"2901976374","geo":{"lt":null,"ln":null},"followers":681},"tweet_id":"812378226639179776"},{"url":"http:\/\/twitter.com\/PLMcCarthyMD\/statuses\/812384733015535617","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T19:49:48+00:00","author":{"name":"Philip McCarthy","image":"https:\/\/pbs.twimg.com\/profile_images\/466351626219823104\/K2IQ5P6I_normal.jpeg","description":"Interested in hematopoietic cell transplantation and hematologic disorders with emphasis on multiple myeloma, AML, ALL, MDS, NHL, HL, CLL, CML","id_on_source":"PLMcCarthyMD","tweeter_id":"454898193","geo":{"lt":42.88645,"ln":-78.87837,"country":"US"},"followers":1934},"tweet_id":"812384733015535617"},{"url":"http:\/\/twitter.com\/DQBMD\/statuses\/812391211889815552","license":"gnip","citation_ids":[12573263],"posted_on":"2016-12-23T20:15:33+00:00","author":{"name":"Qaiser Bashir","image":"https:\/\/pbs.twimg.com\/profile_images\/720985321224077312\/IhoOD56t_normal.jpg","description":"Stem Cell Transplantation | Myeloma | Leukemia | Clinical Trials | Personal views","id_on_source":"DQBMD","tweeter_id":"293100589","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":219},"tweet_id":"812391211889815552"},{"url":"http:\/\/twitter.com\/RenoHemonc\/statuses\/812434579755700224","license":"gnip","rt":["PLMcCarthyMD"],"citation_ids":[12573263],"posted_on":"2016-12-23T23:07:52+00:00","author":{"name":"Santhosh Ambika","image":"https:\/\/pbs.twimg.com\/profile_images\/795184186491473921\/bTOUTHTA_normal.jpg","description":"Doing my part to help onc patients. Pats\/Red Sox\/GSW fan.","id_on_source":"RenoHemonc","tweeter_id":"795174703878942721","geo":{"lt":39.52963,"ln":-119.8138,"country":"US"},"followers":129},"tweet_id":"812434579755700224"},{"url":"http:\/\/twitter.com\/RenoHemonc\/statuses\/812438124169220097","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-23T23:21:57+00:00","author":{"name":"Santhosh Ambika","image":"https:\/\/pbs.twimg.com\/profile_images\/795184186491473921\/bTOUTHTA_normal.jpg","description":"Doing my part to help onc patients. Pats\/Red Sox\/GSW fan.","id_on_source":"RenoHemonc","tweeter_id":"795174703878942721","geo":{"lt":39.52963,"ln":-119.8138,"country":"US"},"followers":129},"tweet_id":"812438124169220097"},{"url":"http:\/\/twitter.com\/marrowdoc\/statuses\/812665736523087873","license":"gnip","rt":["PLMcCarthyMD"],"citation_ids":[12573263],"posted_on":"2016-12-24T14:26:24+00:00","author":{"name":"John McCarty","image":"https:\/\/pbs.twimg.com\/profile_images\/616157605375967232\/0kymqrzl_normal.jpg","description":"Medical Director, BMT and Cellular Therapeutics Laboratory Programs, VCU Massey Cancer Center.  Opinions here are my own.","id_on_source":"marrowdoc","tweeter_id":"1510959414","geo":{"lt":37.55376,"ln":-77.46026,"country":"US"},"followers":170},"tweet_id":"812665736523087873"},{"url":"http:\/\/twitter.com\/marrowdoc\/statuses\/812665844731879424","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-24T14:26:50+00:00","author":{"name":"John McCarty","image":"https:\/\/pbs.twimg.com\/profile_images\/616157605375967232\/0kymqrzl_normal.jpg","description":"Medical Director, BMT and Cellular Therapeutics Laboratory Programs, VCU Massey Cancer Center.  Opinions here are my own.","id_on_source":"marrowdoc","tweeter_id":"1510959414","geo":{"lt":37.55376,"ln":-77.46026,"country":"US"},"followers":170},"tweet_id":"812665844731879424"},{"url":"http:\/\/twitter.com\/nishihori\/statuses\/812689383845412864","license":"gnip","rt":["PLMcCarthyMD"],"citation_ids":[12573263],"posted_on":"2016-12-24T16:00:22+00:00","author":{"name":"Nishihori T","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"Hematologist-Oncologist BMT; Tweets are my personal views","id_on_source":"nishihori","tweeter_id":"20495918","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":134},"tweet_id":"812689383845412864"},{"url":"http:\/\/twitter.com\/erperpersona\/statuses\/813321416657563648","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-26T09:51:51+00:00","author":{"name":"Ernesto P\u00e9rez","image":"https:\/\/pbs.twimg.com\/profile_images\/703251928290074628\/-aW9qP4j_normal.jpg","id_on_source":"erperpersona","tweeter_id":"703249116747399173","geo":{"lt":42.81687,"ln":-1.64323,"country":"ES"},"followers":82},"tweet_id":"813321416657563648"},{"url":"http:\/\/twitter.com\/jose6xxx\/statuses\/814740113099988992","license":"gnip","rt":["BloodJournal"],"citation_ids":[12573263],"posted_on":"2016-12-30T07:49:14+00:00","author":{"name":"Jos\u00e9 L. Garc\u00eda","url":"https:\/\/es.linkedin.com\/in\/jose0","image":"https:\/\/pbs.twimg.com\/profile_images\/610876993354264577\/iveN_9iL_normal.jpg","description":"Especialista en Bioqu\u00edmica Cl\u00ednica y An\u00e1lisis Cl\u00ednicos. Complejo Hospitalario Universitario de Granada","id_on_source":"jose6xxx","tweeter_id":"406496525","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":495},"tweet_id":"814740113099988992"},{"url":"http:\/\/twitter.com\/BindingSiteHaem\/statuses\/820654275412000769","license":"gnip","citation_ids":[12573263],"posted_on":"2017-01-15T15:30:00+00:00","author":{"name":"Binding Site","url":"http:\/\/www.bindingsite.com","image":"https:\/\/pbs.twimg.com\/profile_images\/466145479625949187\/lZH6z1lj_normal.png","description":"Clinical utility of free light chains (Freelite) & heavy\/light chains (Hevylite) in monoclonal gammopathy #myeloma #nephrology Disclaimer http:\/\/hub.am\/1jLoIuK","id_on_source":"BindingSiteHaem","tweeter_id":"875434993","geo":{"lt":52.48142,"ln":-1.89983,"country":"GB"},"followers":819},"tweet_id":"820654275412000769"},{"url":"http:\/\/twitter.com\/BirgerArmstrong\/statuses\/820664848979726336","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2017-01-15T16:12:01+00:00","author":{"name":"Birger Armstrong","image":"https:\/\/pbs.twimg.com\/profile_images\/793570062267478018\/E4zCyG2Y_normal.jpg","description":"I only express my own words & thoughts","id_on_source":"BirgerArmstrong","tweeter_id":"1662345631","geo":{"lt":null,"ln":null},"followers":173},"tweet_id":"820664848979726336"},{"url":"http:\/\/twitter.com\/jose6xxx\/statuses\/821016089295552512","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2017-01-16T15:27:44+00:00","author":{"name":"Jos\u00e9 L. Garc\u00eda","url":"https:\/\/es.linkedin.com\/in\/jose0","image":"https:\/\/pbs.twimg.com\/profile_images\/610876993354264577\/iveN_9iL_normal.jpg","description":"Especialista en Bioqu\u00edmica Cl\u00ednica y An\u00e1lisis Cl\u00ednicos. Complejo Hospitalario Universitario de Granada","id_on_source":"jose6xxx","tweeter_id":"406496525","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":495},"tweet_id":"821016089295552512"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/824252248880533504","license":"gnip","citation_ids":[12573263],"posted_on":"2017-01-25T13:47:04+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"824252248880533504"},{"url":"http:\/\/twitter.com\/VincentRK\/statuses\/824256137646243840","license":"gnip","citation_ids":[12573263],"posted_on":"2017-01-25T14:02:31+00:00","author":{"name":"Vincent Rajkumar","url":"http:\/\/bit.ly\/Z4PHPv","image":"https:\/\/pbs.twimg.com\/profile_images\/3418263560\/a40cbe1b5676b01dff5a8eb86e87c099_normal.jpeg","description":"Edward W & Betty Knight Scripps Professor, Mayo Clinic; Editor, Blood Cancer J; Assoc Editor, Mayo Clin Proceedings; No Financial COI http:\/\/tinyurl.com\/houbsqb","id_on_source":"VincentRK","tweeter_id":"24261916","geo":{"lt":44.02163,"ln":-92.4699,"country":"US"},"followers":5293},"tweet_id":"824256137646243840"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/824258273071263746","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-25T14:11:00+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"824258273071263746"},{"url":"http:\/\/twitter.com\/drkomanduri\/statuses\/824259531630903296","license":"gnip","citation_ids":[12573263],"posted_on":"2017-01-25T14:16:00+00:00","author":{"name":"Krishna Komanduri","url":"https:\/\/www.linkedin.com\/in\/kkomanduri","image":"https:\/\/pbs.twimg.com\/profile_images\/672613124235730945\/teAgt_NY_normal.jpg","description":"Director, Adult Stem Cell Transplant Program, UM Sylvester Cancer, ASBMT President, father of 4 (triplets+1). Personal Account #bmtsm #tcellrx Opinions mine","id_on_source":"drkomanduri","tweeter_id":"1081903728","geo":{"lt":25.77427,"ln":-80.19366,"country":"US"},"followers":3104},"tweet_id":"824259531630903296"},{"url":"http:\/\/twitter.com\/roverome\/statuses\/824319585746882560","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-25T18:14:39+00:00","author":{"name":"Roberto C.  Montoya","image":"https:\/\/pbs.twimg.com\/profile_images\/673175406317555712\/sskHAV9p_normal.jpg","description":"Hematologist-Oncologist, Intrusively curious physician","id_on_source":"roverome","tweeter_id":"26928616","geo":{"lt":null,"ln":null},"followers":314},"tweet_id":"824319585746882560"},{"url":"http:\/\/twitter.com\/ShikhaJainMD\/statuses\/824321390438387712","license":"gnip","citation_ids":[12573263],"posted_on":"2017-01-25T18:21:49+00:00","author":{"name":"Shikha Jain, MD","url":"https:\/\/www.nm.org\/doctors\/1053585463\/shikha-jain-md","image":"https:\/\/pbs.twimg.com\/profile_images\/817545438412869632\/fSz9aJkW_normal.jpg","description":"Hematologist\/Oncologist at Northwestern Memorial Hospital. Mother. Wife. Daughter. Sister. Eternal optimist. Tweets are my own. #cancer #NorthwesternMedicine","id_on_source":"ShikhaJainMD","tweeter_id":"795138728218021889","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":194},"tweet_id":"824321390438387712"},{"url":"http:\/\/twitter.com\/MyelomaTeacher\/statuses\/824352085013622785","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-25T20:23:47+00:00","author":{"name":"Myeloma Teacher","url":"http:\/\/facebook.com\/myelomateacher","image":"https:\/\/pbs.twimg.com\/profile_images\/717171403745832960\/Mcrsrp6c_normal.jpg","description":"Advocate, Ambassador & Mentor, Patient Services Volunteer, @Ash_hematology Speaker, Myeloma Survivor, IRB Member, @CureForward PMA #MMSM #ePatient #canserve","id_on_source":"MyelomaTeacher","tweeter_id":"32530883","geo":{"lt":40.29733,"ln":-74.7296,"country":"US"},"followers":5315},"tweet_id":"824352085013622785"},{"url":"http:\/\/twitter.com\/drcbsteer\/statuses\/824358394018492416","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-25T20:48:51+00:00","author":{"name":"Christopher Steer","url":"http:\/\/www.bordermedonc.com.au","image":"https:\/\/pbs.twimg.com\/profile_images\/698600824935591936\/02tbF1_Z_normal.jpg","description":"Border Medical Oncology |\nAlbury Wodonga Regional Cancer Centre @AWRCCentre |\nPresident http:\/\/pcpa.org.au |\nSIOG, ASCO, COSA, MOGA, MASCC, UNSW | #gerionc","id_on_source":"drcbsteer","tweeter_id":"560286282","geo":{"lt":-36.12179,"ln":146.88809,"country":"AU"},"followers":1964},"tweet_id":"824358394018492416"},{"url":"http:\/\/twitter.com\/e_campagnaro\/statuses\/824371473360027649","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-25T21:40:49+00:00","author":{"name":"Erica Campagnaro","image":"https:\/\/pbs.twimg.com\/profile_images\/831313501310304257\/mKgui4eg_normal.jpg","description":"Enjoying clinical care & research in plasma cell disorders, WM, and a little other B lymphoid stuff at U Mich. My views are my own, don't blame my associations.","id_on_source":"e_campagnaro","tweeter_id":"780584980116156416","geo":{"lt":44.25029,"ln":-85.50033,"country":"US"},"followers":57},"tweet_id":"824371473360027649"},{"url":"http:\/\/twitter.com\/neuherman\/statuses\/824718289687506944","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-26T20:38:57+00:00","author":{"name":"N. Emil U. Hermansen","url":"https:\/\/www.researchgate.net\/profile\/Niels_Emil_Hermansen","image":"https:\/\/pbs.twimg.com\/profile_images\/816283350109392896\/xatq8EAj_normal.jpg","description":"MD, PhD. Senior resident in hematology. Board member of Danish Myeloma Study Group.","id_on_source":"neuherman","tweeter_id":"292516716","geo":{"lt":55.64152,"ln":12.08035,"country":"DK"},"followers":318},"tweet_id":"824718289687506944"},{"url":"http:\/\/twitter.com\/safaridoc\/statuses\/825960655622643712","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-30T06:55:40+00:00","author":{"name":"Al","image":"https:\/\/pbs.twimg.com\/profile_images\/3753513848\/0d299b0b6a9296e25cf0212ea9587e39_normal.jpeg","description":"Blood doc.  Part time clinical researcher.","id_on_source":"safaridoc","tweeter_id":"1455319140","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":8},"tweet_id":"825960655622643712"},{"url":"http:\/\/twitter.com\/MayoMyeloma\/statuses\/826090344546725888","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-30T15:31:00+00:00","author":{"name":"Mayo Myeloma","url":"http:\/\/www.msmart.org","image":"https:\/\/pbs.twimg.com\/profile_images\/132886714\/Myeloma_normal.jpg","description":"Vincent Rajkumar, MD, Professor of Medicine, on behalf of the Mayo Clinic Myeloma Group","id_on_source":"MayoMyeloma","tweeter_id":"30386069","geo":{"lt":44.02163,"ln":-92.4699,"country":"US"},"followers":4744},"tweet_id":"826090344546725888"},{"url":"http:\/\/twitter.com\/AndrewCowanMD\/statuses\/826092037199912961","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-30T15:37:44+00:00","author":{"name":"Andrew Cowan","url":"http:\/\/www.seattlecca.org\/\/doctor\/andrew-j-cowan.cfm","image":"https:\/\/pbs.twimg.com\/profile_images\/692962895873843203\/amWZhVjB_normal.jpg","description":"Clinician-researcher in multiple myeloma, amyloidosis, and Waldenstr\u00f6m's at @SeattleCCA @UW. Former Boston U. Amyloidosis Fellow. Tweets are my own!","id_on_source":"AndrewCowanMD","tweeter_id":"4859281205","geo":{"lt":47.60621,"ln":-122.33207,"country":"US"},"followers":189},"tweet_id":"826092037199912961"},{"url":"http:\/\/twitter.com\/doctoreebs\/statuses\/826147940637011968","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-01-30T19:19:52+00:00","author":{"name":"doctoreebs","url":"http:\/\/humanizepalestine.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/486628078441885696\/5kXszy8O_normal.jpeg","description":"Houston Physician, advocate for justice, Rice alum, UTSW alum. #singlepayer and #BDS supporter #JillStein2016","id_on_source":"doctoreebs","tweeter_id":"288359184","geo":{"lt":null,"ln":null},"followers":88},"tweet_id":"826147940637011968"},{"url":"http:\/\/twitter.com\/BindingSiteHaem\/statuses\/843431861808480257","license":"gnip","citation_ids":[12573263],"posted_on":"2017-03-19T12:00:00+00:00","author":{"name":"Binding Site","url":"http:\/\/www.bindingsite.com","image":"https:\/\/pbs.twimg.com\/profile_images\/466145479625949187\/lZH6z1lj_normal.png","description":"Clinical utility of free light chains (Freelite) & heavy\/light chains (Hevylite) in monoclonal gammopathy #myeloma #nephrology Disclaimer http:\/\/hub.am\/1jLoIuK","id_on_source":"BindingSiteHaem","tweeter_id":"875434993","geo":{"lt":52.48142,"ln":-1.89983,"country":"GB"},"followers":819},"tweet_id":"843431861808480257"},{"url":"http:\/\/twitter.com\/jose6xxx\/statuses\/844286761173966853","license":"gnip","rt":["BindingSiteHaem"],"citation_ids":[12573263],"posted_on":"2017-03-21T20:37:04+00:00","author":{"name":"Jos\u00e9 L. Garc\u00eda","url":"https:\/\/es.linkedin.com\/in\/jose0","image":"https:\/\/pbs.twimg.com\/profile_images\/610876993354264577\/iveN_9iL_normal.jpg","description":"Especialista en Bioqu\u00edmica Cl\u00ednica y An\u00e1lisis Cl\u00ednicos. Complejo Hospitalario Universitario de Granada","id_on_source":"jose6xxx","tweeter_id":"406496525","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":495},"tweet_id":"844286761173966853"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/851988274952450048","license":"gnip","rt":["VincentRK"],"citation_ids":[12573263],"posted_on":"2017-04-12T02:40:08+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"851988274952450048"}],"googleplus":[{"title":"Dejoie et al. assess the performance of serum and urine measurements in 113 newly diagnosed light chain...","url":"https:\/\/plus.google.com\/+BindingSite\/posts\/Grjmpi5DXVj","license":"public","citation_ids":[12573263],"posted_on":"2016-10-13T12:32:28+00:00","summary":"Dejoie et al. assess the performance of serum and urine measurements in 113 newly diagnosed light chain... Dejoie et al. assess the performance of serum and urine measurements in 113 newly diagnosed light chain multiple myeloma (LCMM) patients; specificall"}],"facebook":[{"title":"Blood Journal on Twitter","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1617087761919828&id=1569588320003106","license":"public","citation_ids":[12573263],"posted_on":"2016-12-23T17:19:08+00:00","summary":"#myeloma Serum free light chains at end of Rx as new gold standard response criteria? @BloodJournal https:\/\/t.co\/ezRq8RGPma","author":{"name":"BloodWork","url":"https:\/\/www.facebook.com\/1569588320003106","facebook_wall_name":"BloodWork","image":"https:\/\/graph.facebook.com\/1569588320003106\/picture","id_on_source":"1569588320003106"}}]}}